Spago Nanomedical Balance Sheet Health
Financial Health criteria checks 6/6
Spago Nanomedical has a total shareholder equity of SEK41.3M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK53.0M and SEK11.7M respectively.
Key information
0%
Debt to equity ratio
kr0
Debt
| Interest coverage ratio | n/a |
| Cash | kr45.22m |
| Equity | kr41.32m |
| Total liabilities | kr11.67m |
| Total assets | kr52.99m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 7UX's short term assets (SEK51.9M) exceed its short term liabilities (SEK11.5M).
Long Term Liabilities: 7UX's short term assets (SEK51.9M) exceed its long term liabilities (SEK191.0K).
Debt to Equity History and Analysis
Debt Level: 7UX is debt free.
Reducing Debt: 7UX had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 7UX has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 7UX has sufficient cash runway for 1.3 years if free cash flow continues to reduce at historical rates of 7.5% each year.